FDA Publishes Groundbreaking AI/ML Medical Device Draft Guidance | Nelson Mullins Riley & Scarborough LLP

The U.S. Food and Drug Administration (“FDA”) has announced its first-ever draft guidance specifically addressing the use of artificial intelligence/machine learning (“AI/ML”) in...

Related Keywords

White House ,District Of Columbia ,United States ,Paul Clowes ,Nelson Mullins ,Patient Engagement Advisory Committee Meeting Announcement Oct ,Drug Administration ,Nelson Mullins Riley Scarborough ,Nelson Mullins Riley ,Drug Omnibus Reform Act ,Federal Food ,Cosmetic Act ,Predetermined Change Control Plans ,Draft Guidance ,Premarket Approval ,Implement Device ,Modification Protocol ,Evolving Role ,Artificial Intelligence ,Radiological Imaging ,Public Workshop ,Machine Learning Enabled Medical Devices ,Machine Learning ,Based Software ,Medical Device ,Action Plan ,Modification Protocol Components ,